The DOI matches its Crossref record; 475 of the 475 references it cites were found in a registry or an index.
Adenosine receptors and brain diseases: Neuroprotection and neurodegeneration
Open accessAbstract
Adenosine acts in parallel as a neuromodulator and as a homeostatic modulator in the central nervous system. Its neuromodulatory role relies on a balanced activation of inhibitory A(1) receptors (A1R) and facilitatory A(2A) receptors (A2AR), mostly controlling excitatory glutamatergic synapses: A1R impose a tonic brake on excitatory transmission, whereas A2AR are selectively engaged to promote synaptic plasticity phenomena. This neuromodulatory role of adenosine is strikingly similar to the role of adenosine in the control of brain disorders; thus, A1R mostly act as a hurdle that needs to be overcame to begin neurodegeneration and, accordingly, A1R only effectively control neurodegeneration if activated in the temporal vicinity of brain insults; in contrast, the blockade of A2AR alleviates the long-term burden of brain disorders in different neurodegenerative conditions such as ischemia, epilepsy, Parkinson's or Alzheimer's disease and also seem to afford benefits in some psychiatric conditions. In spite of this qualitative agreement between neuromodulation and neuroprotection by A1R and A2AR, it is still unclear if the role of A1R and A2AR in the control of neuroprotection is mostly due to the control of glutamatergic transmission, or if it is instead due to the different homeostatic roles of these receptors related with the control of metabolism, of neuron-glia communication, of neuroinflammation, of neurogenesis or of the control of action of growth factors. In spite of this current mechanistic uncertainty, it seems evident that targeting adenosine receptors might indeed constitute a novel strategy to control the demise of different neurological and psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Gage, F. H. (2000) · Science · doi:10.1126/science.287.5457.1433 · Cited by 4,786
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Stress and the brain: from adaptation to disease
de Kloet, E. R., Joëls, M., & Holsboer, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1683 · Cited by 4,621
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,962
Flagged first, then by citations
Research works printed but not linked: 3
- Porciúncula, 2006, Blockade of adenosine A 2A receptors differently alters convulsive behaviour and prevents hippocampal damage in two models of temporal lobe epilepsy, Purinergic Signal, 2, 134
- Fernandez, 2008, .U.-C.I. Group, The safety and efficacy of istradephylline, an adenosine A2A antagonist, as monotherapy in Parkinson's disease: results of the KW-6002-US-051 trial, Mov. Disord., 23, S87
- Kaster, 2010, Genetic or pharmacological blockade of adenosine A2A receptors prevents behavioral and morphological effects of chronic stress in mice, Purinergic Signal, 6, S93
Cited by
Sorted by citations
Items 201–300 of 425
Cao, R., Rossetti, G., Bauer, A., & Carloni, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126833 · Cited by 19
Wang, J., Dai, Q., Geng, W.-J., Zhuang, X., Wang, H., Mo, Y., He, X., & Chen, J. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.200806 · Cited by 19
Upregulation of Neuronal Adenosine A1 Receptor in Human Rasmussen Encephalitis
Luan, G., Wang, X., Gao, Q., Guan, Y., Wang, J., Deng, J., Zhai, F., Chen, Y., & Li, T. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx053 · Cited by 19
Chung, Y.-S., Choo, B. K. M., Ahmed, P. K., Othman, I., & Shaikh, M. F. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00692 · Cited by 21
Gao, S., Li, N., Wang, Y., Zhong, Y., & Shen, X. P. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7649080 · Cited by 19
Turčin, A., Dolžan, V., Porcelli, S., Serretti, A., & Plesničar, B. K. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0003 · Cited by 19
Lefin, R., der Walt, M. M. V., Milne, P. J., & Terre’Blanche, G. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.07.071 · Cited by 19
Effect of vitamin B6on brain damage in valproic acid induced toxicity
Türkyılmaz, İ. B., Altaş, N., Arısan, İ., & Yanardağ, R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22855 · Cited by 18
Dias, L., Madeira, D., Dias, R., Tomé, Â. R., Cunha, R. A., & Agostinho, P. M. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04492-y · Cited by 19
Self-citationFu, S.-Y., Xiong, R., Peng, Y., Zhang, Z.-H., Chen, X., Zhao, Y., Ning, Y., Yang, N., Zhou, Y., & Li, P. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02895-1 · Cited by 20
Interaction of selected biomolecules and metabolites with amyloidogenic proteins
Kundu, D., Umesh, & Dubey, V. K. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1760138 · Cited by 18
Adenosine A1modulators: a patent update (2008 to present)
Giorgi, I., & Nieri, P. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.799142 · Cited by 18
Gussago, C., Arosio, B., Casati, M., Ferri, E., Gualandris, F., Tedone, E., Nicolini, P., Rossi, P. D., Abbate, C., & Mari, D. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131652 · Cited by 18
Mitrović, N., Kontić, M. Z., Drakulić, D., Martinović, J., Stanojlović, M., Sévigny, J., Horvat, A., Nedeljković, N., & Grković, I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.022 · Cited by 19
Exercise-Induced Adaptations to the Mouse Striatal Adenosine System
Bauer, E. E., Buhr, T. J., Reed, C. H., & Clark, P. (2020) · Neural Plasticity · doi:10.1155/2020/5859098 · Cited by 17
Food for thought: Impact of metabolism on neuronal excitability
Katsu-Jiménez, Y., Alves, R. M. P., & Giménez-Cassina, A. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.002 · Cited by 18
Methionine Exposure Alters Glutamate Uptake and Adenine Nucleotide Hydrolysis in the Zebrafish Brain
Vuaden, F. C., Savio, L. E. B., Rico, E. P., Mussulini, B. H. M., Rosemberg, D. B., de Oliveira, D. L., Bogo, M. R., Bonan, C. D., & Wyse, Â. T. D. S. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8983-3 · Cited by 18
Duroux, R., Ciancetta, A., Mannes, P. Z., Yu, J., Boyapati, S., Gizewski, E. T., Yous, S., Ciruela, F., Auchampach, J. A., Gao, Z., et al. (2017) · MedChemComm · doi:10.1039/c7md00247e · Cited by 19
Combined Therapy of A1AR Agonists and A2AAR Antagonists in Neuroinflammation
Marucci, G., Ben, D. D., Lambertucci, C., Navia, A. M., Spinaci, A., Volpini, R., & Buccioni, M. (2021) · Molecules · doi:10.3390/molecules26041188 · Cited by 16
Le, L., Li, X., Meng, D., Liang, Q., Wang, X., Li, N., Quan, J., Xiang, M., Jiang, M., Sun, J., et al. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12152 · Cited by 16
Kalash, L. N., Val, C., Azuaje, J., Loza, M. I., Svensson, F., Zoufir, A., Mervin, L., Ladds, G., Brea, J. M., Glen, R. C., et al. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0249-4 · Cited by 17
Neuroprotective Effects of Polydeoxyribonucleotide in a Murine Model of Cadmium Toxicity
Marini, H. R., Puzzolo, D., Micali, A. G., Adamo, E. B., Irrera, N., Pisani, A., Pallio, G., Trichilo, V., Malta, C., Bitto, A., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4285694 · Cited by 16
Aziz, N. A. W. A., Iezhitsa, I. N., Agarwal, R., Kadir, R. F. A., Latiff, A. A., & Ismail, N. M. (2020) · Neurological Research · doi:10.1080/01616412.2020.1716470 · Cited by 16
Caffeine Protects Against Anticonvulsant-Induced Neurotoxicity in the Developing Rat Brain
Endesfelder, S., Weichelt, U., Schiller, C., Sifringer, M., Bendix, I., & Bührer, C. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9768-z · Cited by 16
Seven, Y. B., Simon, A. K., Sajjadi, E., Zwick, A., Satriotomo, I., & Mitchell, G. S. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113067 · Cited by 16
Johnson, R. A. (1974) · PubMed Central · Cited by 16
Naffaa, M. M. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.100676 · Cited by 20
Ibrahim, H. I., Rabie, M. A., Mohamed, R. A., & Nassar, N. N. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110288 · Cited by 15
Sarasola, L. I., del Torrent, C. L., Arévalo, A. P., Argerich, J., Casajuana-Martín, N., Chevigné, A., Fernández‐Dueñas, V., Ferré, S., Pardo, L., & Ciruela, F. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113896 · Cited by 14
Metabolic-driven analytics of traumatic brain injury and neuroprotection by ethyl pyruvate
Golovachev, N., Siebold, L., Sutton, R. L., Ghavim, S. S., Harris, N. G., & Bartnik‐Olson, B. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03280-8 · Cited by 14
Federico, S., Ciancetta, A., Porta, N., Redenti, S., Pastorin, G., Cacciari, B., Klotz, K., Moro, S., & Spalluto, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500752h · Cited by 14
Emamghoreishi, M., Farrokhi, M. R., Amiri, A., & Keshavarz, M. (2019) · PubMed · doi:10.22038/ajp.2019.12385 · Cited by 14
D’Antongiovanni, V., Fornai, M., Pellegrini, C., Blandizzi, C., & Antonioli, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.621955 · Cited by 14
Giust, D., Ros, T. D., Martı́n, M., & Albasanz, J. L. (2014) · Journal of Nanobiotechnology · doi:10.1186/preaccept-1380901054129154 · Cited by 14
Mitrović, N., Stojanović, I. G., Drakulić, D., Stanojlović, M., Martinović, J., Sévigny, J., Horvat, A., Nedeljković, N., & Grković, I. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.06.018 · Cited by 14
Chen, Z. X., Bai, S., Hu, Q., Shen, P., Wang, T., Liang, Z., Wang, W., Qi, X., & Xie, P. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s167448 · Cited by 14
Huin, V., Dhaenens, C., Homa, M., Carvalho, K., Buée, L., & Sablonnière, B. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0011 · Cited by 14
Витальевич, С. В., Ea, E., Erichev, V. P., Yartsev, A. V., Petrov, S. Y., & Александрович, Д. Д. (2020) · Russian Annals of Ophthalmology · doi:10.17116/oftalma202013605158 · Cited by 14
Khanal, S., Thakur, P., Sharma, A., Kumar, A., Pillai, M., Kumar, A., Kumar, A., Verma, R., Tapwal, A., Kumar, V., et al. (2025) · 3 Biotech · doi:10.1007/s13205-025-04353-y · Cited by 13
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
Bassani, D., Pavan, M., Federico, S., Spalluto, G., Sturlese, M., & Moro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094504 · Cited by 13
Aberrant adenosine signaling in patients with focal cortical dysplasia
Guo, M., Zhang, J., Wang, J., Wang, X., Gao, Q., Tang, C., Deng, J., Xiong, Z., Kong, X., Guan, Y., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03351-6 · Cited by 13
Keshavarz, M., Farrokhi, M. R., & Amiri, A. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.069 · Cited by 13
Reklow, R., Alvares, T., Zhang, Y., Tapia, A. P. M., Biancardi, V., Katzell, A., Frangos, S. M., Hansen, M. A., Toohey, A., Cass, C. E., et al. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00365 · Cited by 13
Szopa, A., Bogatko, K., Herbet, M., Serefko, A., Ostrowska-Leśko, M., Wośko, S., Świąder, K., Szewczyk, B., Właź, A., Skałęcki, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041840 · Cited by 13
Tanaka, A., Nishida, K., Okuda, H., Nishiura, T., Higashi, Y., Fujimoto, S., & Nagasawa, K. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.060 · Cited by 14
Yamashiro, K., Fujii, Y., Maékawa, S., & Morita, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13888 · Cited by 14
Domenici, M. R., Chiodi, V., Averna, M., Armida, M., Pèzzola, A., Pepponi, R., Ferrante, A., Bäder, M., Fuxé, K., & Popoli, P. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9609-4 · Cited by 13
Gerbatin, R. R., Dobrachinski, F., Cassol, G., Soares, F. A. A., & Royes, L. F. F. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.014 · Cited by 13
Pieterse, L., der Walt, M. M. V., & Terre’Blanche, G. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127274 · Cited by 13
Mannucci, C., Attard, E., Calapai, F., Facchinetti, F., D’Anna, R., Vannacci, A., Santamaria, A., Lenti, M. C., Righi, M., Perone, M., et al. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1849120 · Cited by 13
Hunt, C. P. J., Pouton, C. W., & Haynes, J. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.01.003 · Cited by 13
The striatum drives the ergogenic effects of caffeine
Alves, A. C. D. B., Speck, A. E., Farias, H. R., Martins, L. M., Santos, N. D. S., Pannata, G., Tavares, A. P., de Oliveira, J., Tomé, Â. R., Cunha, R. A., et al. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09922-5 · Cited by 16
Self-citationDias, L., Nabais, A. M., Borges-Martins, V. P. P., Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.16299 · Cited by 12
Self-citationAdenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
Fernández‐Dueñas, V., Arévalo, A. P., Altafaj, X., Ferré, S., & Ciruela, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00652 · Cited by 12
Perrier, S. P., Gleizes, M., Fonta, C., & Nowak, L. G. (2019) · Physiological Reports · doi:10.14814/phy2.13992 · Cited by 12
Feng, Q., Zhao, M., Gan, T., Zhu, H., Wang, Y., Zhao, S., Wang, Y., Wu, J., & Peng, S. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00874g · Cited by 12
Regulation of Extracellular Adenosine
Boison, D. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_2 · Cited by 12
Fouda, M. A., Leffler, K. E., & Abdel‐Rahman, A. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117598 · Cited by 12
Chen, L., Zhou, Y., Wang, J., Li, K., Zhang, Z., & Peng, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15436 · Cited by 12
Bogatko, K., Poleszak, E., Szopa, A., Wyska, E., Właź, P., Świąder, K., Właź, A., Doboszewska, U., Rojek, K., & Serefko, A. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12954 · Cited by 12
Simões, J. L. B., Sobierai, L. D., Leal, I. F., dos Santos, M. V. R., Coiado, J. V., & Bagatini, M. D. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.12.007 · Cited by 11
Mallozzi, C., Pepponi, R., Visentin, S., Chiodi, V., Lombroso, P. J., Bäder, M., Popoli, P., & Domenici, M. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14866 · Cited by 11
George, A. A., Chinnappan, S. M., Choudhary, Y. K., Choudhary, V. K., Bommu, P., & Wong, H. J. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/375837 · Cited by 11
Luca, M. A. D., Cauli, O., Morelli, M., & Simola, N. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12809 · Cited by 11
Chen, J.-X., Zhang, L., Liu, K., Chen, H., Zhou, S., Wang, N., Tan, Y., Wang, S., Jones, A. L., Yang, F., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00767 · Cited by 12
Effects of Preinjury and Postinjury Exposure to Caffeine in a Rat Model of Traumatic Brain Injury
Lusardi, T. A., Lytle, N. K., Gebril, H. M., & Boison, D. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0012 · Cited by 10
Gori, B., & Girardi, E. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9947-2 · Cited by 10
Serchov, T., Atas, H. C., Normann, C., van Calker, D., & Biber, K. P. H. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8321-6 · Cited by 10
Yeung, P. K. F., Dauphinee, J., & Marcoux, T. (2013) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944712470297 · Cited by 10
Bioinformatics Unmasks the Maneuverers of Pain Pathways in Acute Kidney Injury
Gupta, A., Puri, S., & Puri, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-48209-x · Cited by 11
PET Imaging of Adenosine Receptors in Diseases
Li, J., Hong, X., Li, G., Conti, P. S., Zhang, X., & Chen, K. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190708163407 · Cited by 10
Ren, X.-Y., Rubini, P., Engel, T., Tang, Y., & Illés, P. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107989 · Cited by 9
Boulahjar, R., Arias, A. R., Bolteau, R., Renault, N., Coevoet, M., Barczyk, A., Duroux, R., Yous, S., Melnyk, P., & Agouridas, L. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.04.057 · Cited by 9
Rabanel, J., Delbreil, P., Banquy, X., Brambilla, D., & Ramassamy, C. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.03.035 · Cited by 10
Semwal, B. C., & Garabadu, D. (2020) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08615-1 · Cited by 9
RetractedSoontarapornchai, K., Cai, C. L., Ahmad, T., Aranda, J. V., Hand, I. L., & Beharry, K. D. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073473 · Cited by 9
Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study
Pepponi, R., Simone, R. D., Nuccio, C. D., Visentin, S., Matteucci, A., Bernardo, A., Popoli, P., & Ferrante, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073456 · Cited by 9
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?
Bartoli, F., Carrà, G., & Clerici, M. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1270757 · Cited by 9
Chen, T., Chang, Y.-C., Yu, C., & Sung, W. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16091127 · Cited by 8
Uddin, M. J., Mohaimenul, M., Aktaruzzaman, M., Islam, M. T., Hasan, A. R., Rahman, M. H., Akter, T., Rahman, M. M., Amin, M. Z., & Raihan, M. O. (2024) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2024.09.001 · Cited by 9
Zhang, S., Li, B., Tang, L., Tong, M., Jiang, N., Gu, X., Zhang, Y., Ge, Y., Liu, X., & Chen, J. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.07.014 · Cited by 8
Kutuzov, N. P., Gulin, A. A., Lyaskovskiy, V. L., Nadtochenko, V. A., & Maksimov, G. V. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142084 · Cited by 8
Ammonia: This is not the end but rather the end of the beginning
Weiss, N., Dam, G. A., & Rose, C. F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.027 · Cited by 8
Adenosine Receptors in Alzheimer’s Disease
Canas, P. M., Cunha, R. A., & Agostinho, P. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_11 · Cited by 8
Self-citationNeurogenesis and Gliogenesis: Relevance of Adenosine for Neuroregeneration in Brain Disorders
Mateus, J. M., Ribeiro, F. F., Gomes, M., Rodrigues, R. S., Marques, J. M., Sebastião, A. M., Rodrigues, R. J., & Xapelli, S. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0010 · Cited by 7
Circadian variations of neurotransmitters in the brain – Its importance for neuroprotection
Estrada-Rojo, F., Escobar, C., & Navarro, L. (2020) · Revista de Fomento Social · doi:10.24875/rmn.19000069 · Cited by 10
Schubert, C., Schulz, K., Träger, S., Plath, A.-L., Omriouate, A., Rosenkranz, S. C., Morellini, F., Friese, M. A., & Hirnet, D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.912030 · Cited by 8
Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia
Sahay, S., Devine, E. A., McCullumsmith, R. E., & O'Donovan, S. M. (2023) · Cells · doi:10.3390/cells13010032 · Cited by 8
Bortolatto, C. F., dos Reis, A. S., Pinz, M. P., Voss, G. T., de Oliveira, R. L., Vogt, A. G., Roman, S. S., Jessé, C. R., Luchese, C., & Wilhelm, E. A. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0086-1 · Cited by 8
Hong, S., Li, T., Luo, Y., Li, W., Tang, X., Ye, Y., Wu, P., Hu, Q., Cheng, L., Chen, H., et al. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0590-9 · Cited by 7
Chen, Y., Cai, M., Deng, J., Li, T. X., Wang, S., Li, T., Dong, H., & Xiong, L. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1932-y · Cited by 7
Huang, W. C., Bai, S., Zuo, X., Tang, W., Chen, P., Chen, X., Wang, G., Wang, H., & Xie, P. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3546 · Cited by 9
Activation of A 1 and A 2a adenosine receptors promotes neural progenitor cell proliferation
Lv, J., Shao, Y., & Gao, Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.028 · Cited by 7
Inosine prevents hyperlocomotion in a ketamine-induced model of mania in rats
Camerini, L., Ardais, A. P., Xavier, J., Bastos, C. R., Oliveira, S., Soares, M. S. P., de Mattos, B. D. S., Ávila, A. A., do Couto, C. A. T., Spanevello, R. M., et al. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146721 · Cited by 7
Self-citationYang, B., Balodis, I. M., Hedy Kober, A., Worhunsky, P. D., Lacadie, C., Gelernter, J. E., & Potenza, M. N. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2020.106695 · Cited by 7
Matthee, C., Terre’Blanche, G., Legoabe, L. J., & van Rensburg, H. D. J. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10257-9 · Cited by 7
Dragić, M., Stekić, A., Zeljković, M., Kontić, M. Z., Mihajlović, K., Adžić, M., Grković, I., & Nedeljković, N. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03557-5 · Cited by 7
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective?
Morelli, M., Frau, L., & Simola, N. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.023 · Cited by 7
Caffeine prevents changes in muscle caused by high-intensity interval training
Vieira, J. M., Gutierres, J. M., Carvalho, F. B., Pereira, L. B., Oliveira, L. S., Morsch, V. M., Schetinger, M. R. C., Rodrigues, M., Leitemperger, J., Loro, V. L., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.138 · Cited by 8
Ensandoust, T., Khakpour-Taleghani, B., Jafari, A., Rostampour, M., Rohampour, K., & Hedayati, M. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115210 · Cited by 6
Metadata
- Authors
- Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Cunha, Rodrigo A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 1808
- Issue
- 5
- Pages
- 1380-1399
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2081196843
- Cited by
- 419
- References
- 473
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 15 · 2023: 21 · 2022: 30 · 2021: 24 · 2020: 37 · 2019: 43 · 2018: 36 · 2017: 30 · 2016: 27 · 2015: 38 · 2014: 32 · 2013: 22 · 2012: 26
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Biochimica et Biophysica Acta (BBA) - Biomembranes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação para a Ciência e a Tecnologia
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, neuroprotection, neurodegeneration, neuromodulation, glutamatergic synapses, synaptic plasticity, ischemia, epilepsy, Parkinson's disease, Alzheimer's disease, neuroinflammation, neuron-glia communication, neurogenesis, growth factors, mental illness, adenosine receptor agonists
- MeSH terms
- Animals, Brain Diseases, Humans, Nerve Degeneration, Receptors, Purinergic P1, Neurotransmitter Agents, Neuroprotective Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review